TARDBP and early-onset autosomal dominant Alzheimer disease: Our findings suggest that Alzheimer’s disease cases with amygdala-predominant α-synuclein pathology may constitute a distinct group with more severe hippocampal damage, a higher TDP-43 burden and potential interactions among α-synuclein, TDP-43 and hyperphosphorylated tau.